PRODUCT LITERATURE

Efficacy dose response relationship and safety of once-daily extended-release metformin (Glucophage XR) in type 2 diabetic patients with inadequate glycaemic controlrndespite prior treatment with diet and exercise: results from two double-blind, placebo-controlled studies

---

The efficacy, dose–response relationships and safety of an extended-release formulation of metformin
(Glucophage1 XR) were evaluated in two double-blind, randomized, placebo-controlled studies of 24 and 16 weeks’
duration, in patients with inadequate glycaemic control despite diet and exercise. Protocol 1 provided an evaluation
of metformin XR at a commonly used dosage. Protocol 2 evaluated different dosages of metformin XR

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

GLUMIN XR

Specific Detail Info

-

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment